Concord Healthcare Grp Co Ltd (2453.HK)

54,400 -0,050 (-0,09%) Alla chiusura: 04:08PM HKT

Concord Healthcare Grp Co Ltd

East Tower, Hanwei Building
Room 26A1-26A5 No. 7 Guanghua Road Chaoyang District
Beijing 100020
China
86 10 5903 6688
https://www.concordmedical.com

Settore/i: Healthcare
Settore: Medical Care Facilities
Impiegati a tempo pieno: 733

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Jianyu Yang	Executive Chairman of the Board	1,9M	N/D	1971
Ms. Xiao Fu	GM, President & Executive Director	1,91M	N/D	1967
Mr. Liang Chang	VP & Executive Director	1M	N/D	1981
Mr. Botao Shi	Secretary & Executive Director	796,13k	N/D	1975
Ms. Ying Chang	Chief Financial Officer	N/D	N/D	1983
Mr. Lichen Pan	Joint Company Secretary	N/D	N/D	N/D
Ms. Wing Nga Ho	Joint Company Secretary	N/D	N/D	1972

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in HKD.

Descrizione

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People's Republic of China. It operates in two segments, Hospital Business; and Medical Equipment, Software and Related Services. The company also offers oncology-related services, including sales and installing of medical equipment and software; management and technical support services to hospitals; and operating lease services. In addition, it engages in leasing of radiotherapy and diagnostic imaging equipment; trading of radiotherapy and diagnostic imaging equipment; technology promotion and application solutions; medical treatment and service, and equipment trading activities; and provision of cancer treatment services. The company was incorporated in 2008 and is headquartered in Beijing, China.

Governance aziendale

L'ISS Governance QualityScore di Concord Healthcare Grp Co Ltd al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.